[ Price : $8.95]
CDERs Office of Prescription Drug Promotion says that an Alcon Pataday rebate card fails to meet requirements for reminder adverti...[ Price : $8.95]
Tarsa Therapeutics says it will file an NDA in the second half of 2012 for Ostora (recombinant salmon calcitonin), an oral tablet ...[ Price : $8.95]
FDA approves an InfraScan de novo petition permitting the marketing of its hand-held Infrascanner Model 1000 device, intended to a...[ Price : $8.95]
FDA again denies a 2006 citizen petition from the Center for Reproductive Rights that seeks over-the-counter (OTC) status for the...[ Price : $8.95]
FDAs Florida District Office warns Pace Tech about Quality System and Medical Device Reporting violations in its manufacturing of ...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Galloway Technologies, 5 Surgery Centers marketing the Lap Band, and Pace Tech.[ Price : $8.95]
Vertex and Alios say they are starting Phase 1 trials of two nucleotide analogs to determine their safety and tolerability for pot...[ Price : $8.95]
FDA says it has potential review concerns after assigning a 12-month standard review for an Onyx Pharmaceuticals NDA for carfilzom...